Chronic exposure to TXA2 increases expression of ROCKI in human myometrial cells

Prostaglandins and Other Lipid Mediators

Volumn 71, Issue 1-2, 2003, Pages 23-32

  Moore, Frances ^a   López Bernal, Andrés ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Caspase 3; Human uterine smooth muscle; Protein expression; RhoA associated protein kinase I; Thromboxane A2; U46619

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; BENZYLOXYCARBONYLASPARTYLGLUTAMYLVALYLASPARTYL FLUOROMETHYL KETONE; CASPASE 3 INHIBITOR; DRUG ANALOG; EXOTOXIN; ISOPROTEIN; P 160 RHO A ASSOCIATED PROTEIN KINASE 1; RECEPTOR BLOCKING AGENT; THROMBOXANE A2 DERIVATIVE; UNCLASSIFIED DRUG; CALCIUM; CASPASE; DRUG DERIVATIVE; ISOENZYME; PROTEIN SERINE THREONINE KINASE; RHO KINASE; RHO-ASSOCIATED KINASE; SIGNAL PEPTIDE; THROMBOXANE A2; THROMBOXANE RECEPTOR;

ACUTE DRUG ADMINISTRATION; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EXPOSURE; DRUG INHIBITION; FEMALE; HUMAN; HUMAN TISSUE; MYOMETRIUM; PROTEIN DEGRADATION; PROTEIN EXPRESSION; TISSUE CULTURE CELL; UTERUS CONTRACTILITY; UTERUS CONTRACTION; BIOSYNTHESIS; CELL CULTURE; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; METABOLISM; PHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PREGNANCY; WESTERN BLOTTING;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; BLOTTING, WESTERN; CALCIUM; CASPASES; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME ACTIVATION; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; ISOENZYMES; MYOMETRIUM; PREGNANCY; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, THROMBOXANE; THROMBOXANE A2;

EID: 0037387301     PISSN: 00906980     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-6980(02)00150-8     Document Type: Article

References (25)

1. Word R.A., Stull J.T., Casey L., Kamm K.E.J. Contractile elements and myosin light chain phosphorylation in myometrial tissue from nonpregnant and pregnant women. Clin. Invest. 92:1993;29.
2. Mackay D.J.G., Hall A.J. Rho GTPases. Biol. Chem. 273:1998;20685.
3. Somylo A.P., Somlyo A.V.J. From pharmacomechanical coupling to G-protein and myosin phosphatase. Acta Physiol. Scand. 164:1998;437.
4. 2. Fed. Proc. (United States). 46:1987;133.
5. 2 synthase gene. J. Clin. Endocrinol. Metab. 78:1998;1225.
6. 2 have potent and differentiated actions on human uterine contractility. Prostaglandins. 21:1981;277.
7. Senior J., Sangha R., Baxter G.S., Marshall K., Clayton J.K. In vitro characterization of prostanoid FP-, DP-, IP- and TP-receptors on the non-pregnant human myometrium. Br. J. Pharmacol. 107:1992;215.
8. Dyal R., Crankshaw D.J. The effects of some synthetic prostanoids on the contractility of the human lower uterine segment in vitro. Am. J. Obstet. Gynecol. 158:1998;281.
9. Senchyna M., Crankshaw D.J. Characterization of the prostanoid TP receptor population in human nonpregnant myometrium. J. Pharmacol. Exp. Ther. 279:1996;262.
10. Senior J., Marshall K., Sangha R., Clayton J.K. In vitro characterization of prostanoid receptors on human myometrium at term pregnancy. Br. J. Pharmacol. 108:1993;501.
11. Coleman R.A., Smith W.L., Narumiya S. International Union of Pharmacology Classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol. Rev. 46:1994;205.
12. 2 receptors: where have you gone? Prostaglandins Other Lipid Mediat. 60:2000;175.
13. 2 receptor. J. Biol. Chem. 270:1995;7011.
14. 2 receptor α and β isoforms. J. Biol. Chem. 274:1999;8941.
15. Moore F., Asbóth G., López Bernal A. Thromboxane receptor signalling in human myometrial cells. Prostaglandins Other Lipid Mediat. 67:2002;19.
16. Moore F., Da Silva C., Wilde J., Watson S.P., López Bernal A. Increased expression of RhoA- and p21-activated protein kinases in human pregnant myometrium. Biochem. Biophys. Res. Commun. 269:2000;322.
17. Sebbagh M., Renvoizé C., Hamelin J., Riché N., Bertoglio J., Bréard J. Caspase-3-mediated cleavage of ROCKI induces MLC phosphorylation and apoptotic blebbing. Nat. Cell Biol. 3:2001;346.
18. Coleman M.L., Sahai E.A., Yeo M., Bosch M., Dewar A., Olson M.F. Membrane blebbing during apoptosis results from caspase-mediated activation of ROCKI. Nat. Cell Biol. 3:2001;339.
19. 11 induces caspase-mediated proteolytic activation of Rho-associated kinase, ROCKI, in HeLa cells. J. Biol. Chem. 276:2001;42527.
20. Casey M.L., MacDonald P.C., Mitchell M.D., Snyder J.M. Maintenance and characterization of human myometrial smooth muscle cells in monolayer culture. In Vitro. 20:1984;396.
21. Phaneuf S., Europe-Finner G.N., Varney M., MacKenzie I.Z., Watson S.P., López Bernal A. Oxytocin-stimulated phosphoinositide hydrolysis in human myometrial cells: involvement of pertussis toxin-sensitive and -insensitive G-proteins. J. Endocrin. 136:1993;497.
22. 2 in vascular smooth muscle. Biochem. Pharmacol. 40:1990;2535.
23. Craven P.A., Studer R.K., DeRubertis F.R. Thromboxane/prostaglandin endoperoxide-induced hypertrophy of rat vascular smooth muscle cells is signaled by protein kinase C-dependent increases in transforming growth factor-β Hypertension. 28:1996;169.
24. Noort W.A., Keirse M.F. Prostacyclin versus thromboxane metabolite excretion: changes in pregnancy and labor. Eur. J. Obstet. Gynecol. Reprod. Biol. 35:1990;15.
25. 2 and threatened preterm. WCUMS. 29:1998;315.